Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15

Ji,Hong; Lu,Hong‑Wei; Li,Yi‑Ming; Lu,Le; Wang,Jin‑Long; Zhang,Ya‑Fei; Shang,Hao

doi:10.3892/mmr.2015.3867

Twist promotes invasion and cisplatin resistance in pancreatic cancer cells through growth differentiation factor 15

Authors:
- Hong Ji
- Hong‑Wei Lu
- Yi‑Ming Li
- Le Lu
- Jin‑Long Wang
- Ya‑Fei Zhang
- Hao Shang
View Affiliations

Affiliations: Department of General Surgery, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China
Published online on: May 27, 2015 https://doi.org/10.3892/mmr.2015.3867
Pages: 3841-3848

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pancreatic cancer (PC) is an aggressive and devastating disease with a poor prognosis. Cisplatin, a commonly used chemotherapeutic agent for solid tumors, is effective as a single agent or in combination with other drugs for the treatment of PC. Previous studies have suggested that Twist and growth differentiation factor 15 (GDF15) are involved in the progression of PC. However, the role of Twist and GDF15 in PC remains to be elucidated. In the present study, the individual effect of and interaction between Twist and GDF15 in PC cell invasion and chemoresistance to cisplatin was examined. Twist and/or GDF15 were stably overexpressed or knocked down in ASPC‑1 and BXPC‑3 human PC cells. Overexpression of Twist in the two cell lines markedly increased GDF15 expression, cell invasion, matrix metalloproteinase‑2 expression/activity and the half maximal inhibitory concentration (IC50) values of cisplatin, which was eradicated by GDF15 knockdown or the selective p38 mitogen‑activated protein kinase (MAPK) inhibitor SB203580 (10 µM). By contrast, Twist knockdown significantly decreased GDF15 expression, cell invasion, matrix metalloproteinase‑2 expression/activity and the IC50 values of cisplatin, which was completely reversed by overexpression of GDF15. In addition, while overexpression and knockdown of Twist increased and decreased p38 MAPK activity, respectively, GDF15 demonstrated no significant effect on p38 MAPK activity in PC cells. In conclusion, the present study, for the first time, to the best of our knowledge, demonstrated that Twist promotes PC cell invasion and cisplatin chemoresistance through inducing GDF15 expression via a p38 MAPK‑dependent mechanism. The present study provides new insights into the molecular mechanisms underlying PC progression and chemoresistance.

View Figures

View References

1	Jiang H, Duan B, He C, et al: Cytoplasmic HSP90α expression is associated with perineural invasion in pancreatic cancer. Int J Clin Exp Pathol. 7:3305–3311. 2014.
2	Spano JP, Chodkiewicz C, Maurel J, et al: Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: An open-label randomised phase II study. Lancet. 371:2101–2108. 2008. View Article : Google Scholar : PubMed/NCBI
3	López R, Méndez CM, Fernández MJ, et al: Phase II trial of erlotinib plus capecitabine as first-line treatment for metastatic pancreatic cancer (XELTA study). Anticancer Res. 33:717–723. 2013.PubMed/NCBI
4	Hidalgo M: Pancreatic cancer. N Engl J Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
5	Chung TW, Choi HJ, Kim SJ, et al: The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cells. PLoS One. 9:e927862014. View Article : Google Scholar : PubMed/NCBI
6	Gresham GK, Wells GA, Gill S, Cameron C and Jonker DJ: Chemotherapy regimens for advanced pancreatic cancer: A systematic review and network meta-analysis. BMC Cancer. 14:4712014. View Article : Google Scholar : PubMed/NCBI
7	Ramfidis VS, Psyrri A, Syrigos KN and Saif MW: First line treatment for metastatic pancreatic adenocarcinoma: Looking for the step forward. JOP. 15:286–288. 2014.PubMed/NCBI
8	Entz-Werlé N, Choquet P, Neuville A, et al: Targeted apc;twist double-mutant mice: A new model of spontaneous osteosarcoma that mimics the human disease. Transl Oncol. 3:344–353. 2010. View Article : Google Scholar : PubMed/NCBI
9	Ohuchida K, Mizumoto K, Ohhashi S, et al: Twist, a novel oncogene, is upregulated in pancreatic cancer: Clinical implication of Twist expression in pancreatic juice. Int J Cancer. 120:1634–1640. 2007. View Article : Google Scholar : PubMed/NCBI
10	Breit SN, Johnen H, Cook AD, et al: The TGF-β superfamily cytokine, MIC-1/GDF15: A pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors. 29:187–195. 2011. View Article : Google Scholar : PubMed/NCBI
11	Mimeault M and Batra SK: Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer. J Cell Physiol. 224:626–635. 2010. View Article : Google Scholar : PubMed/NCBI
12	Khaled YS, Elkord E and Ammori BJ: Macrophage inhibitory cytokine-1: A review of its pleiotropic actions in cancer. Cancer Biomark. 11:183–190. 2012.PubMed/NCBI
13	Koopmann J, Buckhaults P, Brown DA, et al: Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res. 10:2386–2392. 2004. View Article : Google Scholar : PubMed/NCBI
14	Ozkan H, Demirbaş S, Ibiş M, Akbal E and Köklü S: Diagnostic validity of serum macrophage inhibitor cytokine and tissue polypeptide-specific antigen in pancreatobiliary diseases. Pancreatology. 11:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
15	Chen YZ, Liu D, Zhao YX, Wang HT, Gao Y and Chen Y: Diagnostic performance of serum macrophage inhibitory cytokine-1 in pancreatic cancer: A meta-analysis and meta-regression analysis. DNA Cell Biol. 33:370–377. 2014. View Article : Google Scholar : PubMed/NCBI
16	Matsuo N, Shiraha H, Fujik T, et al: Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer. 9:2402009. View Article : Google Scholar : PubMed/NCBI
17	Wang B, Feng P, Xiao Z and Ren EC: LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma. J Hepatol. 50:528–537. 2009. View Article : Google Scholar : PubMed/NCBI
18	Feng Y, Hu J, Ma J, et al: RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Eur J Cancer. 47:2353–2363. 2011. View Article : Google Scholar : PubMed/NCBI
19	Jo YK, Park SJ, Shin JH, et al: ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells. Biochem Biophys Res Commun. 404:1039–1043. 2011. View Article : Google Scholar
20	Qazi H, Shi ZD and Tarbell JM: Fluid shear stress regulates the invasive potential of glioma cells via modulation of migratory activity and matrix metalloproteinase expression. PLoS One. 6:e203482011. View Article : Google Scholar : PubMed/NCBI
21	Ding X, Zhang Z, Li S and Wang A: Combretastatin A4 phosphate induces programmed cell death in vascular endothelial cells. Oncol Res. 19:303–309. 2011. View Article : Google Scholar : PubMed/NCBI
22	Wang X, Wu H and Miller AH: Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function. Mol Psychiatry. 9:65–75. 2004. View Article : Google Scholar
23	Leelahavanichkul K, Amornphimoltham P, Molinolo AA, Basile JR, Koontongkaew S and Gutkind JS: A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis. Mol Oncol. 8:105–118. 2014. View Article : Google Scholar :
24	Li Y, Liao Q, Li K, Zhong D, Weng X and Mi M: Knockdown of endothelin A receptor expression inhibits osteosarcoma pulmonary metastasis in an orthotopic xenograft mouse model. Mol Med Rep. 5:1391–1395. 2012.PubMed/NCBI
25	Cui XP, Qin CK, Zhang ZH, et al: HOXA10 promotes cell invasion and MMP-3 expression via TGFβ2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells. Dig Dis Sci. 59:1442–1451. 2014. View Article : Google Scholar : PubMed/NCBI
26	Pan F, Ma S, Cao W, et al: SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines. Mol Biol Rep. 40:4139–4146. 2013. View Article : Google Scholar : PubMed/NCBI
27	Wu J, Liao Q, He H, Zhong D and Yin K: TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin. Mol Carcinog. 53:440–446. 2014. View Article : Google Scholar
28	Bauskin AR, Brown DA, Kuffner T, et al: Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res. 66:4983–4986. 2006. View Article : Google Scholar : PubMed/NCBI